MedDiet adherence doesn't affect acute heart failure mortality

December 8, 2017

(HealthDay)—For patients with acute heart failure, adherence to the Mediterranean diet (MedDiet) does not influence long-term mortality, according to a study published online Dec. 6 in JACC: Heart Failure.

Òscar Miró, Ph.D., from the University of Barcelona in Spain, and colleagues conducted a prospective study involving with in seven Spanish emergency departments. Data were included for 991 patients, of whom 52.9 percent were adherent to the MedDiet.

The researchers observed no significant differences in survival between adherent and nonadherent patients after a mean follow-up of 2.1 ± 1.3 years (hazard ratio of adherents [HRadh], 0.86; 95 percent confidence interval [CI], 0.73 to 1.02). For the whole cohort, the one-year cumulative emergency department revisit was 24.5 percent (HRadh, 1.10; 95 percent CI, 0.84 to 1.42), hospitalization 43.7 percent (HRadh, 0.74; 95 percent CI, 0.61 to 0.90), death 22.7 percent (HRadh, 1.05; 95 percent CI, 0.8 to 1.38), and combined end point 66.8 percent (HRadh, 0.89; 95 percent CI, 0.76 to 1.04). Similar results were seen after adjustment for confounding variables, with no statistically significant differences in mortality (HRadh, 0.94; 95 percent CI, 0.80 to 1.13); lower one-year hospitalization for adherents persisted (HRadh, 0.76; 95 percent CI, 0.62 to 0.93).

"Adherence to the MedDiet did not influence long-term mortality after an episode of acute failure, but it was associated with decreased rates of rehospitalization during the next year," the authors write.

The research group received funding from Orion Pharma and Novartis.

Explore further: Simple tool accurately predicts 30-day mortality for patients with acute heart failure in the ER

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Simple tool accurately predicts 30-day mortality for patients with acute heart failure in the ER

October 2, 2017
A simple tool using readily available data can accurately estimate the 30-day mortality risk for patients admitted to the emergency department with acute heart failure. Emergency department physicians may consider using this ...

Nonadherence to statins plus ACEIs/ARBs risky post MI

September 23, 2017
(HealthDay)—Nonadherence to angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) and/or statins following acute myocardial infarction (AMI) is associated with higher mortality, according ...

Risk conferred by T2D modified by HbA1c in heart failure

October 12, 2017
(HealthDay)—For patients with heart failure, the risks conferred by type 2 diabetes (T2D) can be stratified by glycemic control and drug treatments, according to a study published online Oct. 11 in JACC: Heart Failure.

Beta-blocker use not linked to reduced mortality after AMI

June 1, 2017
(HealthDay)—β-blocker use is not associated with reduced mortality after acute myocardial infarction (AMI) without heart failure or left ventricular systolic dysfunction (LVSD), according to a study published in the June ...

Not adhering to recommended exams for severe narrowing of the aortic valve associated with increased heart failure

September 6, 2017
Patients with asymptomatic severe aortic stenosis who did not follow recommended guidelines for regular exams had poorer survival and were more likely to be hospitalized for heart failure, according to a study published by ...

1998 to 2014 saw drop in CVD hospitalization rates in diabetes

November 28, 2017
(HealthDay)—Cardiovascular disease (CVD) hospitalization rates have declined in recent years among individuals with and those without diabetes, according to a study published online Nov. 17 in Diabetes Care.

Recommended for you

Eating yogurt may reduce cardiovascular disease risk

February 15, 2018
A new study in the American Journal of Hypertension, published by Oxford University Press, suggests that higher yogurt intake is associated with lower cardiovascular disease risk among hypertensive men and women.

Newly discovered gene may protect against heart disease

February 14, 2018
Scientists have identified a gene that may play a protective role in preventing heart disease. Their research revealed that the gene, called MeXis, acts within key cells inside clogged arteries to help remove excess cholesterol ...

Blood thinners may raise stroke risk in over-65s with kidney disease

February 14, 2018
People over 65 years old may be increasing their stroke risk by taking anticoagulants for an irregular heartbeat if they also have chronic kidney disease, finds a new study led by UCL, St George's, University of London and ...

Cardiac macrophages found to contribute to a currently untreatable type of heart failure

February 14, 2018
A team of Massachusetts General Hospital (MGH) investigators has discovered, for the first time, that the immune cells called macrophages contribute to a type of heart failure for which there currently is no effective treatment. ...

Study maps molecular mechanisms crucial for new approach to heart disease therapy

February 13, 2018
Creating new healthy heart muscle cells within a patient's own ailing heart. This is how scientists hope to reverse heart disease one day. Today, a new study led by UNC-Chapel Hill researchers reveals key molecular details ...

Quality toolkit improves care in Indian hospitals

February 13, 2018
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.